Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 3.1 Companies Law, 5759 1999
- 4.3 EX-4.3
- 10.1 Licence Agreement
- 10.2 Execution Copy
- 10.3 Consortium Agreement
- 10.4 Israeli Share Option Plan
- 10.5 Management Services Agreement
- 10.6 Employment Agreement
- 10.7 EX-10.7
- 10.8 Biondvax Pharmaceuticals LTD .
- 10.9 Biondvax
- 10.10 Summary of the Lease Agreement
- 10.11 Addendum to Employment Agreement Dated April 1, 2012, Between Biondvax Pharmaceuticals LTD. and DR. Tamar Ben Yedidia.
- 10.12 Addendum to Service Agreement Dated August 31, 2014, Between Biondvax Pharmaceuticals LTD., CFO Direct and Uri Ben
- 10.13 Employment Agreement Dated August 31, 2014, Between Biondvax Pharmaceuticals LTD. and Uri Ben Or.
- 10.14 Letter of Appointment of Prof. Ethan Rubinstein to Biondvax Pharmaceuticals LTD.'S Scientific Advisory Board Dated January 15, 2004.
- 10.15 Letter of Appointment of Prof. Michel Revel to Biondvax Pharmaceuticals LTD.'S Scientific Advisory Board Dated February 14, 2005.
- 10.16 Letter of Appointment of Prof. Ruth Arnon to Biondvax Pharmaceuticals LTD.'S Scientific Advisory Board Dated February 7, 2005, Together with the Amendment Thereto Dated December 29, 2005.
- 23.1 Consent of Independent Registered Public Accounting Firm
SCNI similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated November 11, 2014, in the Registration Statement (Form F-1) and related Prospectus of Biondvax Pharmaceuticals Ltd. dated December 29, 2014.
Tel Aviv, Israel | |
December 29, 2014 | Kost Forer Gabbay & Kasierer |
A Member of Ernst & Young Global |